Critical appraisal of the views of healthcare professionals with respect to pharmacogenomics and personalized medicine in Greece
Critical appraisal of the views of healthcare professionals with respect to pharmacogenomics and personalized medicine in Greece
复制标题
DOI：
10.2217/pme.13.92
复制
发表时间：
2014-01-01
影响因子：
2.3
通讯作者：
Patrinos, George P.
中科院分区：
文献类型：
--
作者：
Mai, Yuan;Mitropoulou, Christina;Patrinos, George P.
目的：在后基因组时代，在许多欧洲国家，人们对医疗保健专业人员对药物基因组学和个性化医疗的认识水平知之甚少。研究方法：在这里，我们报告了一项深入研究的结果，涉及86名药剂师和208名医生，以评估他们对药物基因组学和个性化医疗的认识水平。结果如下：我们的研究结果表明，大约60%的药剂师认为他们的个性化医疗知识水平非常低，而超过一半的药剂师和医生表示，他们无法向客户或患者解释药物基因组学测试的结果。这种情况可能与他们的遗传学和药物基因组学本科教育水平低直接相关。结论：这些研究结果提供了评估的基础上，在希腊的个性化医疗的医疗保健专业人员的意见，并应有助于促进基因组学整合到医疗决策过程。
Aim: In the postgenomic era, in many European countries, very little is known regarding the level of awareness of healthcare professionals with respect to pharmacogenomics and personalized medicine. Methods: Here, we report the findings of an in-depth study, involving 86 pharmacists and 208 physicians, to assess their level of awareness of pharmacogenomics and personalized medicine. Results: Our findings indicate that approximately 60% of pharmacists consider their level of knowledge of personalized medicine to be very low, while over half of the pharmacists and physicians intimate that they would be unable to explain the results of pharmacogenomic tests to their customers or patients, respectively. This situation may be directly related to the low level of their undergraduate education in genetics and pharmacogenomics. Conclusion: These findings provide the basis for assessing the views of healthcare professionals in relation to personalized medicine in Greece, and should help to facilitate the integration of genomics into the medical decision-making process.